AI-audited under CosmeticFountain methodology v3.1.
Holds every marketing claim against the applicable regulatory frame, including the cosmetics rules and sunscreen guidance relevant to each market. It flags wording that is too broad or too close to a health promise.
Maps the available evidence on the active ingredient and on the finished product. It qualifies the size, design, independence and closeness of each source to the promise under analysis.
Cross-checks observable usage feedback and tolerance signals to qualify the gap between controlled data and everyday use. It does not turn customer opinions into clinical evidence.
Identifies groups or situations that call for caution: pregnancy, breastfeeding, children, damaged skin, photosensitivity, dermatological care or known conditions.
Audits the absence of commercial influence on the verdict, the score and the display order. It separates retailer availability from the editorial conclusion.
Checks the completeness of transparency statements: affiliation, AI, sources, method, prices and limits. It blocks dossiers missing information essential to the reader.
The analyses published on CosmeticFountain are produced by an artificial-intelligence system. This information is given to you in the spirit of Article 50 of Regulation (EU) 2024/1689 and UK transparency expectations. The provider, model and version of the system will be published here before commercial launch.
CosmeticFountain does not present these analyses as individual expertise or health advice. The legal items still open are listed in the launch file and the editorial policy.
The Feynman registry holds 47 expert profiles that can be drawn on; actual use varies by product category, with 43 profiles used for the Anthelios UVMune 400 dossier.
